Should Investors Worry About Moderna's Vaccine Delays?
Moderna (NASDAQ: MRNA) recently announced that it's run into some problems shipping some doses of its COVID-19 vaccine mRNA-1273. However, the company stated that these should only be short-term issues. In this Motley Fool Live video, recorded on Feb. 17, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not investors should worry about the potential impact of these delays.
Source Fool.com
